Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lucion

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 40
Average round size
info
The average size of a deal this fund participated in
$47M
Portfolio companies 33
Rounds per year 1.67
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon

Areas of investment

  • Biotechnology
  • Manufacturing
  • Health Care
  • Medical
  • Biopharma
Summary

In 2000 was created Lucion, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Jinan. The company was established in Asia in China.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The real fund results show that this Corporate Investor is 40 percentage points more often commits exit comparing to other companies.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Clinical Trials, Digital Media. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight XGIMI, Airwing.ai, Ruiyi Biotechnology (Realbio Technology).

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Lucion, startups are often financed by CrestValue, Chengdu Technology Transfer Group, CDF-Capital. The meaningful sponsors for the fund in investment in the same round are Wuxi Capital, Sichuan Culture Industry Fund, Sailing Capital. In the next rounds fund is usually obtained by Country Garden, Ant Financial.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lucion:
Typical Co-investors
Lucion is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lucion:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Keylights

Health Care
Health Diagnostics
Medical
$15M12 Jan 2024 Shenzhen, Guangdong, China

ACXEL Tech

Consumer
Consumer Electronics
Electronics
$15M01 Jan 2024 Foshan, Guangdong, China

CVA Chip

Intelligent Systems
Semiconductor
$30M13 Nov 2023 Shenzhen, Guangdong, China

Best Ray

Information Technology
Laser
Manufacturing
15 Sep 2023 Jinan, Shandong, China

Tage Zhixing

Automotive
Product Research
Transportation
$61M01 Sep 2023 Beijing, Beijing, China

Xinhuan Technology

Biotechnology
Health Care
Medical
28 Aug 2023 Shenzhen, Guangdong, China

Anhui YOFC Advanced Semiconductor

Manufacturing
Semiconductor
$587M28 Jun 2023 Wuhu, Anhui, China

Jitong Life

Biotechnology
Life Science
Medical
25 Jun 2023 Suzhou Shi, Jiangsu, China

Jingcai Intelligent

Artificial Intelligence
Health Care
Medical
20 Jun 2023 Haidian, Beijing, China
News
ABclonal Biotechnology Completes $93 Million Series C Financing

– ABclonal Biotechnology, a global life science tools and services provider, recently completed its $92.9 million Series C financing led by Sequoia Capital China and healthcare-focused investor LYFE Capital.
– Other new and existing shareholders, such as Sigma Square Capital, Kinghall Ventures, and Lucion Capital, participated in the new round.
– ABclonal Biotechnology, parent company of Massachusetts-based life science research and diagnostic reagents manufacturer, ABclonal Technology, will use the additional funding to accelerate the company’s research and development pipeline for in vitro diagnostic raw materials and rapidly expand production capabilities of its research reagent products and services.
– ABclonal is also currently in talks to acquire a contract research organization focused on single-cell-based monoclonal antibody development. This will be the company’s first step toward using the $92.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lucion?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 40
Average round size 47M
Rounds per year 1.67
Peak activity year 2023
Lead investments 6
Follow on index 0.17
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Keylights

Health Care
Health Diagnostics
Medical
$15M12 Jan 2024 Shenzhen, Guangdong, China

ACXEL Tech

Consumer
Consumer Electronics
Electronics
$15M01 Jan 2024 Foshan, Guangdong, China

CVA Chip

Intelligent Systems
Semiconductor
$30M13 Nov 2023 Shenzhen, Guangdong, China

Best Ray

Information Technology
Laser
Manufacturing
15 Sep 2023 Jinan, Shandong, China

Tage Zhixing

Automotive
Product Research
Transportation
$61M01 Sep 2023 Beijing, Beijing, China

Xinhuan Technology

Biotechnology
Health Care
Medical
28 Aug 2023 Shenzhen, Guangdong, China

Anhui YOFC Advanced Semiconductor

Manufacturing
Semiconductor
$587M28 Jun 2023 Wuhu, Anhui, China

Jitong Life

Biotechnology
Life Science
Medical
25 Jun 2023 Suzhou Shi, Jiangsu, China

Jingcai Intelligent

Artificial Intelligence
Health Care
Medical
20 Jun 2023 Haidian, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: